Another study showed that miR-29a, which targets the ATG9A and TFEB mRNAs, is down-regulated in Pancreatic Ductal Adenocarcinoma (PDAC) leading to increased ATG9A levels, autophagy flux and resistance to gemcitabine, as well as increased cancer cell migration. This evidence concerns the gene TFEB and cancer.